FDA approves second brain imaging drug to help evaluate patients for ... FDA.gov FDA approves second brain imaging drug to help evaluate patients for Alzheimer's disease, dementia. The U.S. Food and Drug Administration today approved Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission ... |